Adi Rasayan informs about rectified outcome of board meeting

29 Sep 2015

With reference to the earlier annoucement dated September 28, 2015, regarding Oucome of Board Meeting, Adi Rasayan has now informed that the Board of Directors at their meeting held on September 28, 2015, have subject to the approval of the Hon’ble High Court, shareholders. Stock Exchanges where the shares of the Company are listed and other relevant regulatory authorities approved the reduction of Equity Share Capital of the Company from Rs 6,51,97,000  divided into 65,19,700 Equity Shares of Rs 10 each fully paid-up to Rs 32,59,850 divided in to 3,25,985 Equity Shares of Rs 10 each fully paid up and such reduction be effected by canceling Rs 10 per share on 61,93,715 Equity Shares amounting to Rs 6,19,37,150 in the existing paid up Equity Share Capital against debit balance in Profit and Loss account. The Board of Directors has also decided to appoint advisors/consultants for Valuation Report, Fairness opinion and other relevant matters.

The above information is a part of company’s filings submitted to BSE.

Related Generic Pharmasec Ltd. Links:

Generic Pharmasec Share Price

13.36 0.00 (0.00%) Dec 10, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sudarshan Chemicals 396.40
Kiri Industries 353.10
Bhageria Industries 92.75
Shree Pushkar Chem 86.15
Poddar Pigments 162.45
View more..
Sensex vs Generic Pharmasec
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463